| | 158930-09-7 Basic information More.. |
| Product Name: | Frovatriptan Succinate | | Synonyms: | FrovatriptanSuccinate;(3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate;1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1);1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1);Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1);Sb-209509ax;Vml 251;Fovatriptan succinate | | CAS: | 158930-09-7 | | MF: | C18H23N3O5 | | MW: | 361.4 | | EINECS: | | | Mol File: | 158930-09-7.mol |  |
Use
Frovatriptan is also a moderately potent full agonist at 5-HT7 receptors, which have a dilatory action and are expressed in the human coronary artery. In vitro studies appear to indicate frovatriptan’s functional selectivity for cerebral circulation as shown by the concentrations needed to induce threshold contractile activity and maximum response in basilar arteries as compared with coronary arteries.
- Frovatriptan Succinate
-
- US $3100.00-1820.00 / mg
- 2025-10-27
- CAS:158930-09-7
- Min. Order:
- Purity:
- Supply Ability: 10g
|
|
158930-09-7
Recommend Suppliers |
|